ReNeuron Group plc RNUGF
Set alert
At close · Oct 29
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0007
- Prev close
- 0.0011
- Mkt cap
- 62.89K
- Vol
- 500
- Avg vol
- 0
- EPS
- -0.11
- P/E
- 0.00
More statistics
- Low
- 0.0007
- High
- 0.0007
News
2 years ago proactiveinvestors.co.uk
ReNeuron set to delist after it calls time on equity fundraising effort
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it would delist from AIM after it called time on City fundraising efforts to focus on the ongoing administration process. In an update, the company said…
2 years ago proactiveinvestors.co.uk
ReNeuron says funding talks ongoing
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it is seeking potential new investors to enable the company to trade as a going concern following an exit from administration. However, there is a…
2 years ago proactiveinvestors.co.uk
ReNeuron may have a future as a listed company, investors and creditors told
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), the stem cell group placed into administration in March, said it is exploring an equity fundraiser to recapitalise the business. In an update, it was…
2 years ago proactiveinvestors.com
ReNeuron to showcase drug delivery platform at Cell2023
ReNeuron is to present in vivo data exemplifying the cellular and tissue targeting capabilities and highlighting the significant advantages of its CustomEX drug delivery platform at Cell 2023 in…
3 years ago proactiveinvestors.com
ReNeuron highlights exosome platform R&D progress
ReNeuron said it had taken an important step forward with plans to differentiate its exosome platform by generating in vivo data highlighting its distinct organ and cellular targeting capabilities.…